Pages

Showing posts with label Brazil. Show all posts
Showing posts with label Brazil. Show all posts

Friday, 23 June 2017

The Worst Kind of Meat


June 21, 2017

worst meats

Story at-a-glance

  • The first large-scale animal farms were designed to protect egg-laying hens from predators and extreme weather, but quickly grew to include meat farmers who used technical advances to increase profits
  • Today, concentrated animal feeding operations are often run by contract farmers who are under the thumb of large corporations; the farmers often invest millions in facilities and equipment while being paid a flat rate
  • Corporations are fighting for global domination of the meat market through large mergers, buyouts and even bribing of politicians that have in some instances resulted in billion dollar fines and prison sentences
By Dr. Mercola
The first large-scale animal farm factories appeared in the early 1970s,1 designed for egg-laying hens. However, it wasn't long before beef and pork producers followed suit with the aim to reduce overhead and increase profits, which also reduced the quality of the meat produced.
Today, most meat sold in the U.S. is raised in concentrated animal feeding operations (CAFOs). In a corporate-controlled environment characterized by large-scale, centralized production, companies — not farmers — have identified means of production, processing and distribution that produce more meat for less money.
The repercussions associated with these farms have included a rise in antibiotic-resistant disease claiming the lives of nearly 23,000 Americans each year,2 and a significant impact on local water supply from waste water runoff from these farms.3,4 Both of these concerns are driving significant global issues with water quality and antibiotic-resistant bacterial disease.
Although these farms have created monstrous environmental problems, the companies that run them are not only violating the environment, they are also plundering the American farmer, driving the farmer deeper into debt as the corporation enjoys growing profits.

Moved From Field to Confinement

Harold Steele, a hog-farming pioneer in central Illinois, helped develop new methods of raising pigs in automated confinement operations that boosted productivity.5 Family farmers were optimistic these new production methods would help improve sustainable agriculture on the family farm. Initially, wooden barns and then galvanized metal sheds, were built to protect the animals from predators, cold snaps and summer heat.
Farmers shared their secrets for breeding, shed construction and ventilation systems. The farmers started with wooden slat floors that allowed manure and waste to collect below, but soon moved to concrete floors when the wood swelled and twisted from moisture. The farmers built earthen lagoons to stockpile the manure and then used it to fertilize their nearby crop fields where they grew corn and grain to feed the livestock.
These farmers used secret additives to the hog feed, such as cinnamon and honey to improve production and reduce illness. However, by the 1990s, low-dose, government-approved growth hormones and antibiotics were introduced, making the animals grow faster, and sometimes changing their personality. Steele said:6
"The animals changed from what we had created to a kind of animal that was being fed things that they shouldn't have been fed. They are no longer animals that we've known. They are animals that we can't even handle."
As the animals are packed in tight quarters and fed diets that endanger the animal's immune system, the spread of disease occurs quickly and easily. Low dose antibiotics are added to the feed to slow infectious disease and to encourage growth of the animal on less food; both factors that increase the profit margin for the producers and increase the health risks for the end user.
These antibiotics may kill most of the bacteria in the animal, but often leave enough bacteria resistant to the drugs that survive and multiply in the meat.7 This is the meat that ends up on your dinner table.

Resistance to Antibiotic of Last Resort Found on Hog Farm

Antibiotic-resistant bacteria is fast becoming a global crisis,8 fueled by large amounts of antibiotic use on CAFO farms, needed to protect the health of animals kept in an unhealthy and inhumane environment. One such antibiotic-resistant bacteria recently detected on a U.S. hog farm9 was carbapenem-resistant enterobacteriaceae (CRE).
CRE has been labeled a "nightmare bacteria" by the former director of the Centers for Disease Control and Prevention, Dr. Tom Frieden, since they are nearly impossible to kill with conventional antibiotics.10 These organisms may transfer their virility to other bacteria, have a fatality rate as high as 50 percent and are resistant to nearly all antibiotics.
Researchers suggested finding CRE on the hog farm may have been the result of an introduction from the outside. The consistent use of low-dose antibiotics in the animal feed on the farm may subsequently have contributed to the maintenance and spread of the bacteria.11

Some Contract Growers Lose Out

The system of pork production initiated by Steele continued until the mid-1990s when prices collapsed and large producers, such as Smithfield and Cargill, entered the picture, enticing farmers to become "contract growers," providing the labor without actually owning the pigs.12 Some farmers saw this as a way of being able to keep the family farm without absorbing the fluctuating meat market prices.
According to the Food and Agriculture Organization of the United Nations, while farmers are insulated from shifting prices, they face unique challenges, such as increasing production losses or corruption in the sponsoring company, especially allocating quotas the farmers must meet.13 Large meat producers, like Cargill, are continuing to solicit contract growers, giving the farmer the opportunity to get bank loans for new confinement buildings and stay in business.
But while a contract from a large corporation promising business may help the farmer garner a bank loan, the reality of a 365-day business without rest and consistent payment per pig has driven some farmers out of business. According to Professor Emeritus Ronald Plain, a specialist in livestock marketing at the University of Missouri, the cost per pig:14
"[It] sounds fairly typical. What you are describing is a very common arrangement. You want to make a lot of money in pigs, you got to own the pigs and deal with a lot of risk."
Without the risk, farmers are making less but continue to have the same overhead costs. Some have taken out multimillion-dollar loans to build confinement facilities15 while netting between $20,000 and $60,000 each year for their efforts. According to Illinois hog farmer Greg Giertz:
"It used to be, the farmer raised the corn that fed his pigs here in Illinois, they got harvested by a packing plant here in Illinois and they probably got consumed here in Illinois. Now the hogs might be owned by someone in Iowa, raised in Illinois, slaughtered in Indiana and shipped to China."

Smithfield Profits and Farmers Can Barely Pay the Mortgage

Solicitation of a greater number of contract farmers has resulted in nearly 700 construction applications for new or expanded operations in Iowa alone.16 This follows the loss of nearly 8 million piglets between 2013 and 2015 from a viral infection of porcine epidemic diarrhea virus (PEDv).17 Multiple strains of PEDv have been identified in the U.S., as the virus easily mutates in response to herd immunity.
The enteric virus was reported in the 1970s18 in Europe and found periodically in Italy since the 1990s.19 Severe outbreaks occurred predominantly in swine-producing Asian countries, before destroying nearly 10 percent of the hog population in the U.S. between 2013 and 2014. The virus then spread to Canada and Mexico.20 Confinement and stressed immune systems in the hogs increased the opportunity for the virus to spread quickly.
Lack of supply drove pork prices high, reducing consumer demand. With an increasing number of contract farmers taking the initiative to develop pork CAFOs to meet the demand, the market has been flooded with "the other white meat," making pork more competitive in the grocery store. Throughout the ups and downs of the pork market, contract farmers are paid the same for each pig delivered to market, while their overhead costs continue to grow.
This combination has resulted in a $143 million net income for Smithfield in 2016, compared to $83 million for the same time period in 2015.21 Pig farmers are facing declining margins and potential farm loss, while the companies that own their contracts are raking in the profits.
The fall in prices comes at a time when export to China has fallen dramatically, in part as China bans the use of a growth stimulant U.S. producers use to add weight on the animal before slaughter. Ractopamine is a drug that increases protein development and reduces the amount of fat on the animal. However, while it sounds good for producers, the drug is banned in most countries, except the U.S., due to health concerns.
Animal research links the drug to a reduction in reproductive function, birth defects, mastitis in dairy animals and an increase in death. In fact, the Center for Food Safety includes toxicity risks as behavioral changes, cardiovascular and endocrine problems and high stress leading to broken limbs, hyperactivity and death.22 The drug is banned in nearly 160 countries, but acceptable to the U.S. Food and Drug Administration for your consumption.23

What Does Health Have to Do With It?

In a marketing maneuver to brand Smithfield CAFO pork as healthy, the company partnered with Skinnygirl brand to launch a new line of cold cut meats.24 These new prepackaged, portion controlled servings are purposefully aimed at "health conscious, weight-watching, young women," according to Smithfield.25
Skinnygirl brand was started by one of the reality television actresses on the Real Housewives of New York, Bethenny Frankel, who endorses the new portion-controlled packages of pork, saying,26 "Protein is the key to feeling full and satisfied, which helps us avoid bad investment foods."
However, while protein is necessary for good health in small portions, it is healthy fats that increase your satiety and feeling of satisfaction and fullness after eating a healthy meal, and not bits of protein, especially not antibiotic and growth hormone-laden CAFO pork.

Speak Softly and Carry a Big Stick

Reminiscent of President Theodore Roosevelt's foreign policy to "speak softly and carry a big stick," Smithfield appears to be taking up a position of intelligent marketing and decisive action to advance a global impact on the meat market. Slowly and quietly the company is targeting markets across the globe using popular branding, such as Skinnygirl, and collaborating with major league sports teams, such as the Chicago Fire Soccer Club.
Krakus, a polish subsidiary of Smithfield, recently announced they would team up with the Chicago soccer team to provide the official deli meat for the season.27 The irony of pairing of a sports team, intent on physical fitness, with a company providing CAFO pork products is a clever marketing strategy to push you to associate healthy life choices with prepackaged deli meat.
Smithfield foods is also applying for permission to acquire more meat processing plants in Poland,28 to grow their ever-expanding meat empire across the globe. The proposal involves the purchase of 100 percent of company shares of three meat processing plants. The proposed acquisition will add the ability of Smithfield to process poultry meat in Poland, boosting meat processing capacity in that country. Smithfield said in a statement to Global Meat News:29
"The acquisition will strengthen the integrated supply chain within Smithfield group in Poland. It will also allow [the group] to raise its production capacities in the field of meat processing to satisfy the increasing demand of Polish and foreign customers for … processed meat products."
If the proposed merger with Smithfield and these four plants takes place, the plants in Poland will likely post annual revenues of nearly $270 million. Although consolidation of meat processing and packing is lucrative for Smithfield, it places contract farmers and consumers in the untenable position of being at the mercy of one provider.

Political Bribes Release Tainted Meat and May Topple Brazilian President

The meat business, much like other large industries, has connections at various levels of government. In the case of meat exports from Brazil, those connections have reached all the way to the country's president. Recently, authorities in Brazil suspended 33 government employees and closed three slaughterhouses after finding factory managers had bribed politicians and inspectors to obtain meat export certificates for meat that had never been inspected.30
This was the largest organized federal police effort in Brazil, which police used to dismantle a "criminal organization" that had used kickbacks to aid the production and exportation of adulterated meat by meat producer JBS.
Brazil is one of the world's largest meat exporters, generating nearly $14 billion in the global meat trade in 2016. Located in Brazil, JBS is a global organization, having acquired U.S. Swift and Company in 2007 and Smithfield's beef business in 2008. In 2009 JBS became a majority stockholder in Pilgrim's Pride.
As a result of corruption charges, Brazilian prosecutors fined JBS $3.1 billion, which will be paid by their holding company J&F. This assessment came on the heels of another plea agreement between the Brazilian government and JBS that included reduced sentences for seven executives from the company.31
Although JBS did not disclose the corruption charges, investigations into President Michael Temer were launched following a leaked recording of Temer condoning a JBS executive to bribe politician Eduardo Cunha,32 now serving 15 years after being found guilty of tax evasion, money laundering and corruption.33
In the recording, Temer appears to discuss payments to Cunha. The allegations, and ensuing economic turmoil, have resulted in the country's Supreme Court approving an inquiry into these accusations against President Temer and has ousted the chairman of JBS, Joesley Batista, who reportedly fled to New York aboard his yacht, before returning to Brazil June 11.34 JBS is now in the process of selling its beef concerns in Argentina, Uruguay and Paraguay.35

Sustainable Farming Combats Antibiotic-Resistant Disease

Each year the importance to combating antibiotic-resistant disease grows stronger. You may do your part to protect your health by carefully choosing your foods and using antibiotics for yourself responsibly. Seek out antibiotic-free meat raised by organic grass fed and regenerative farmers. If you live in the U.S., the following organizations may help you locate healthy farm-fresh foods:

The goal of the American Grassfed Association is to promote the grass fed industry through government relations, research, concept marketing and public education.
Their website also allows you to search for AGA approved producers certified according to strict standards that include being raised on a diet of 100 percent forage; raised on pasture and never confined to a feedlot; never treated with antibiotics or hormones; born and raised on American family farms.

EatWild.com provides lists of farmers known to produce raw dairy products as well as grass fed beef and other farm-fresh produce (although not all are certified organic). Here you can also find information about local farmers markets, as well as local stores and restaurants that sell grass fed products.

Weston A. Price has local chapters in most states, and many of them are connected with buying clubs in which you can easily purchase organic foods, including grass fed raw dairy products like milk and butter.

The Grassfed Exchange has a listing of producers selling organic and grass fed meats across the U.S.

This website will help you find farmers markets, family farms and other sources of sustainably grown food in your area where you can buy produce, grass fed meats and many other goodies.

A national listing of farmers markets.


The Eat Well Guide is a free online directory of sustainably raised meat, poultry, dairy and eggs from farms, stores, restaurants, inns, hotels and online outlets in the United States and Canada.

CISA is dedicated to sustaining agriculture and promoting the products of small farms.


The FoodRoutes "Find Good Food" map can help you connect with local farmers to find the freshest, tastiest food possible. On their interactive map, you can find a listing for local farmers, CSAs and markets near you.


The Cornucopia Institute maintains web-based tools rating all certified organic brands of eggs, dairy products and other commodities, based on their ethical sourcing and authentic farming practices separating CAFO "organic" production from authentic organic practices.


If you're still unsure of where to find raw milk, check out Raw-Milk-Facts.com and RealMilk.com. They can tell you what the status is for legality in your state, and provide a listing of raw dairy farms in your area. The Farm to Consumer Legal Defense Fund36 also provides a state-by-state review of raw milk laws.37 California residents can also find raw milk retailers using the store locator available at www.OrganicPastures.com.



Wednesday, 22 March 2017

Hong Kong import ban deals Brazil meat industry big blow

Brazil's giant meat industry suffered a heavy blow Tuesday, when Hong Kong became the latest to ban imports in response to allegations of rotten meat being sold with falsified certificates.

Experts analyse meat seized in markets in Rio de Janeiro, Brazil, on March 20, 2017
Experts analyse meat seized in markets in Rio de Janeiro, Brazil, on March 20, 2017
Hong Kong is the biggest market for Brazilian beef, importing $718 million worth in 2016, according to Brazilian government figures.
Hong Kong's Centre for Food Safety said it had temporarily suspended the import of frozen and chilled meat and poultry "in view of the fact that the quality of the meat from Brazil is in question."
This followed a similar ban by China, which is Brazil's biggest market for beef and poultry overall.
South Korea, for its part, lifted a temporary suspension on the distribution of chicken already imported from Brazil, after authorities there performed quality inspections and confirmed that no tainted poultry had entered the country.
It has no plans to close its market to Brazilian meat, the South Korean embassy in Brasilia said.
But the European Union earlier demanded a stop to exports by four companies implicated in the scandal, while Chile suspended all meat imports, prompting Brazil to threaten retaliatory measures against its Latin American trade partner.
Mexico issued its own ban on poultry imports late Tuesday, saying it wanted Brazil "to show scientific proof and guarantees of the sanitary level, quality and safety" of the produce.
Brazil's neighbor Argentina announced it was ready for "an even greater increase in the usual (quality) controls."
Japan, which is Brazil's third biggest market for chicken, with $720 million in sales, said it would not allow imports of products from the 21 businesses under investigation in Brazil.
And Russia, which has heavily relied on Brazilian imports since banning US and European Union food imports, said it wanted clarifications from Brazil.
"We expect more than 30 countries to question Brazil about this issue," Brazilian Agriculture Minister Blairo Maggi said Monday.
- National 'embarrassment' -
Officials have been scrambling to contain the damage since Brazilian police announced the results of a two-year investigation on Friday.
According to police, health inspectors were bribed to certify meat no longer fit for consumption, while additives were used to mask problems in the produce.
Brazil meat export crisis widens
Brazil meat export crisis widens
Exports have been stopped from all 21 meat processors under investigation, and at least 30 people have been arrested.
A poultry-processing plant run by the multinational BRF group and two meat-processing plants operated by the local Peccin company were shut down.
Brazil exports meat to more than 150 countries, with 2016 sales of beef and poultry reaching more than $10 billion.
Total meat exports amount to about seven percent of exports and 0.7 percent of gross domestic product, according to Capital Economics.
The Folha newspaper reported that 21 meat processing companies forced to halt exports while they undergo investigation represent less than one percent of total Brazilian meat exports.
However, the damage to the industry's reputation could be far reaching, hitting Brazil just as the country struggles to exit its worst recession in history.
President Michel Temer called the quantities involved in the scandal "insignificant" on Tuesday, but he admitted there had been "an embarrassment."
The scandal also broke right ahead of negotiations to seek a free-trade accord between the European Union and several South American countries including Brazil.
France and other European countries are wary about opening up the EU meat market to countries in the South American Mercosur bloc, which includes major exporters Brazil and Argentina. Paraguay and Uruguay are the other members.
http://www.dailymail.co.uk/wires/afp/article-4335466/Hong-Kong-bans-Brazilian-meat-imports.html

Saturday, 10 September 2016

Larvicide Manufactured By Sumitomo, Not Zika Virus, True Cause Of Brazil's Microcephaly Outbreak: Doctors

The microcephaly outbreak in Brazil, which coincided with the spread of the Zika virus, continues to stun the world, even months after the incident was first reported.

14 February 2016, 8:58 am EST
By Alyssa Navarro Tech Times 

A group of Argentine physicians claim that the sudden microcephaly outbreak in Brazil was not caused by the Zika virus, but by a larvicide injected into the country's water supplies.  ( Mario Tama | Getty Images ) 

Pregnant women all over the world have been advised to take caution. The Zika virus infection has been linked to newborn babies with the birth defect microcephaly. This is a congenital condition in which babies are born with unusually tiny heads.

The notion, however, has recently been challenged by a group of Argentine physicians. The group suspects that the Zika virus is not to blame for the rise in microcephaly cases, but that a toxic larvicide introduced into Brazil's water supplies may be the real culprit.

Not A Coincidence?

According to the Physicians in Crop-Sprayed Towns (PCST), a chemical larvicide that produces malformations in mosquitoes was injected into Brazil's water supplies in 2014 in order to stop the development of mosquito larvae in drinking water tanks.

The chemical, which is known as Pyriproxyfen, was used in a massive government-run program tasked to control the mosquito population in the country. Pyriproxyfen is a larvicide manufactured by Sumitomo Chemical, a company associated [PDF] with Monsanto. 

However, PCST has referred to Sumitomo as a subsidiary of Monsanto.

"Malformations detected in thousands of children from pregnant women living in areas where the Brazilian state added pyriproxyfen to drinking water is not a coincidence," the PCST wrote [pdf] in the report.

For instance, the Brazilian Health Ministry had injected pyriproxyfen to reservoirs in the state of Pernambuco. In the area, the proliferation of the Aedes aegypti mosquito, which carries the Zika virus, is very high, the PCST said.

Pernambuco is also the first state in Brazil to notice the problem. The state contains 35 percent of the total microcephaly cases in the country.

The group of Argentine doctors points out that during past Zika epidemics, there have not been any cases of microcephaly linked with the virus. In fact, about 75 percent of the population in countries where Zika broke out had been infected by the mosquito-borne virus.

In countries such as Colombia where there are plenty of Zika cases, there are no records of microcephaly linked to Zika, the group said.

When the Colombian president announced that many of the country's citizens were infected with Zika but that there was not a single case of microcephaly, the allegations soon emerged. Some 3,177 pregnant women in the country were infected with Zika, but the PCST report said these women are carrying healthy fetuses or had given birth to healthy babies.

Remain Skeptical

On its website, Sumitomo Chemical says pyriproxyfen poses minimal risk to birds, fish and mammals.

However, the evidence is overwhelming. The Washington Post reported in January that after experts examined 732 cases out of 4,180 Zika-related microcephaly, more than half were not related to Zika at all. Only 270 cases were confirmed as Zika-linked microcephaly.

On top of all the suspicions, however, the World Health Organization (WHO) has been careful not to explicitly link Zika to microcephaly.

"Although a causal link between Zika infection in pregnancy and microcephaly — and I must emphasize — has not been established, the circumstantial evidence is suggestive and extremely worrisome," said WHO General Director Margaret Chan.

In the meantime, scientists are currently racing toward developing a vaccine for the mosquito-borne infection.

While there is no solid proof yet that the larvicide causes microcephaly, the local government of Grande do Sul in the southern portion of Brazil suspended the use of the chemical larvicide pyriproxyfen.

A Monsanto representative reached out to Tech Times to clarify that the company does not sell or manufacture pyriproxyfen.

"Neither Monsanto nor our products have any connection to the Zika virus or microcephaly. 
Monsanto does not manufacture or sell Pyriproxyfen. And, Monsanto does not own Sumitomo Chemical Company. It is, however,  a business partner like others in the area of crop protection," the representative said.

Pyriproxyfen manufacturer Sumitomo Chemical also released a statement to reassure that its product is safe for use.

"Pyriproxyfen, after going through extensive toxicological testing, has shown no effects on the reproductive system or nervous system in mammals, and has been approved and registered for use in the past 20 years by the authorities of around 40 countries around the world," Sumitomo said. "...despite long term and widespread use in many different settings no correlation with microcephaly has been reported."

http://www.techtimes.com/articles/133548/20160214/monsanto-larvicide-not-zika-virus-true-cause-of-brazils-microcephaly-outbreak-doctors.htm


Sunday, 19 October 2014

New hepatitis cure far too costly

October 13, 2014

This post is on Healthwise

Martin Khor


BY MARTIN KHOR


A new cure for hepatitis C has given new hope, but its price is far too high, while a scheme to supply poor countries excludes Malaysia and other middle-income countries.
A CONTROVERSY is brewing over a new cure for hepatitis C because it is extremely expensive and patients in middle-income countries like Malaysia will find it way beyond their budget.
There are an estimated 400,000 Malaysians with hepatitis C, but this is probably a significant under-estimate since many people are not aware that they have the virus.
Worldwide, 170 million people live with the hepatitis C virus (HCV), and every year three to four million more are infected, and there are around 350,000 deaths.
Hepatitis C is thus a major public health problem and called a “silent killer” because it can lead to serious liver ailments including cancer for those who are infected.
The good news is that a new drug, sofosbuvir, was approved last year by the American health authorities.
The medicine has an effective rate of around 90%, making it superior to the older medicines which have a lower success rate and some serious side effects.
The bad news is that the producer, the US firm Gilead, put a very high price tag of US$84,000 (RM274,428) for a 12-week course.
Each pill thus costs US$1,000 (RM3,267).
The price could be set so high because the older and less effective alternatives cost about a third of that level, and the company also argued that a liver transplant (which the new medicine’s cure would make unnecessary) would cost much higher.
Revenue from the new medicine since late last year has already run into many billions of dollars.
At that kind of price, only the very rich can afford the new medicine.
Patients in the West have difficulty even if they are insured, as the insurance companies or the National Health Service might not be able to put this expensive drug on their approved list.
There is now a wave of anger among health and patients’ groups throughout the world.
Here is a life-saving medicine which is being priced out of reach, because the patents being filed by the company prevents competitors producing cheaper versions.
Opposition to a patent application was filed in India by a group, Initiative for Medicines, Access and Knowledge, on the ground that the drug made use of an existing compound.
In Indian law, patents need not be given for new uses of existing medicines or their compounds.
Facing mounting opposition, Gilead came up with a new initiative.
It made agreements with seven companies in India, allowing them to produce their own versions of sofosbuvir as well as another medicine, ledipasvir (which can be taken in combination), at prices these companies will set themselves.
A study at Liverpool University found that a full course of generic sofosbuvir could cost as low as US$101 (RM330) and ledipasvir, US$93 (RM303).
Another estimate is that the cost could be US$135-US$400 (RM441-RM1,306).
Thus the Indian companies’ prices are expected to be well below a thousand dollars.
An example from a decade ago is useful. When medicines for HIV-AIDS sold for US$15,000 (RM49,005) a patient a year, Indian companies produced generic versions for US$350 (RM1,143) a patient a year, and their prices fell further to about US$65 (RM212) today.
There is, however, a major flaw in this new plan. While the agreements allow the Indian companies to sell the medicine in India and in some other countries, they are not allowed to market it in 51 middle-income developing countries.
Malaysia is one of these countries, together with 50 others including Thailand, the Philippines, China, Brazil and Argentina.
Patients and governments in these countries will thus be blocked from obtaining the cheap medicine coming from India.
The originator company plans to sell its brand in these excluded countries and thus reap high profits.
The price they charge may be less than US$84,000 (RM274,428), but significantly higher than the Indian companies’ prices.
The medical group, Medicins Sans Frontiers, has criticised this discrimination.
It said: “Hepatitis C is especially prevalent in middle-income countries, with approximately 73% of the burden in these countries. But disappointingly many of these countries remain excluded from accessing Gilead’s lowest price and the generic versions licensed by these agreements.”
Patients in the excluded countries have expressed their anger. In Malaysia, the Positive Malaysian Treatment Access and Advocacy Group and the Third World Network said the new oral medicines bring new hope for hepatitis C patients but these hopes were dashed by the restrictive terms of the agreements, thus “condemning to death many of the 50 million HCV patients living in territories excluded from the scope from the voluntary licence such as Malaysia, Thailand, Philippines and China”.
Thirteen Thai NGOs issued a statement that they are appalled by the agreement that the originator signed with the Indian companies, which they said represented “corporate greed building yet another barrier to access to a new medicine needed by millions with hepatitis C infection in middle-income countries.
“In those middle-income countries not included in the deal, millions of people will be effectively handed a death sentence as the new life-saving medicine will be unaffordable.”
The Brazilian Network for Integration of Peoples said it “vehemently repudiates the agreements which treat medicines as commodities, preventing millions of people to have access to medicines”.
Patients in the affected countries, and their support groups, including the above, are calling on their governments to act to ensure that their citizens have access to the new medicines.
The countries are allowed by the WTO’s intellectual property agreement not to grant patents if the medicines are not new or genuine inventions.
If patents have been granted, the governments can issue compulsory licences that allow generic companies or government firms to produce and sell generic medicines at cheap prices.
Alternatively, the governments can ask the company to include their countries to be among those that the Indian companies can supply to, or else that the prices charged by the company are the same as the cheapest generics.
> Martin Khor is executive director of the South Centre, a research centre of 51 developing countries, based in Geneva. You can e-mail him at director@southcenter.org. The views expressed here are entirely his own.

Go to Healthwise for more articles

http://www.thestar.com.my/Opinion/Columnists/Global-Trends/Profile/Articles/2014/10/13/New-hepatitis-cure-far-too-costly/

http://healthticket.blogspot.my/2016/03/foreign-patients-turn-to-india-in.html